お知らせ • Jul 25

A group of buyers led by Fall Line Endurance Fund, Lp, managed by Fall Line Capital, LLC completed the acquisition of GreenLight Biosciences Holdings (NasdaqGM:GRNA) from stockholders.

An affiliate of Fall Line Endurance Fund, Lp, managed by Fall Line Capital, LLC enter into a preliminary non-binding proposal to acquire GreenLight Biosciences Holdings (NasdaqGM:GRNA) from stockholders for $84.1 million on March 29, 2023. A group of buyers led by Fall Line Endurance Fund, Lp, managed by Fall Line Capital, LLC entered into a definitive agreement to acquire GreenLight Biosciences Holdings (NasdaqGM:GRNA) from a group of shareholders for $45.5 million on May 29, 2023. As part of the bid, Fall Line Endurance will acquire all of the outstanding shares of common stock for $0.60 per share in cash. GreenLight’s Board of Directors through a special committee thereof (the “Special Committee”) will carefully evaluate Fall Line’s indication of interest within the context of the ongoing review of various alternatives and in consultation with any financial and legal advisors it may retain. Any definitive agreement entered into in connection with the Proposed Transaction would be subject to customary closing conditions, including approval by the Special Committee, any required stockholder approvals and approval by any applicable regulatory authorities. Pursuant to the terms of the merger agreement, and subject to the conditions set forth therein, Fall Line, together with its affiliates, agreed that it will commence a tender offer (the “Offer”) to acquire all of the outstanding shares of common stock of the Company (the “Company Common Stock”), other than certain excluded shares, for $0.30 per share (the “Offer Price”), net to the seller in cash, without interest thereon, and subject to any required withholding, upon the terms and subject to the conditions of the merger agreement. The Offer Price represents a 50% premium to the closing price of the Company’s Common Stock as of May 26, 2023, the last trading day prior to the date of this announcement. In connection with the transactions contemplated by the merger agreement, certain existing stockholders of the Company, together holding approximately 79.5% of the outstanding shares of the Company Common Stock, entered into contribution and exchange agreements pursuant to which such stockholders agreed to contribute their shares of Company Common Stock in exchange for shares of Series A-2 Preferred Stock of a newly formed holding company (the “Private Company”) that will own 100% of the Company upon the consummation of the transactions contemplated by the merger agreement. In addition, in connection with the transactions contemplated by the Merger Agreement, Fall Line and certain investors entered into a Secured Convertible Note Purchase Agreement (the “Note Purchase Agreement”), to which the Company is a third-party beneficiary and under which the Private Company shall issue up to $100 million of Convertible Secured Promissory Notes (the “Private Company Notes”) to the investors at the closing of the Merger Agreement, of which $52.075 million is committed as of the date hereof. In connection therewith, the Company will receive $15.0 million of cash and will issue $15.0 million of unsecured notes (the “Advance Notes”) for the purpose of providing working capital to the Company on May 30, 2023. At the closing of the merger, the Advance Notes shall automatically be exchanged for Private Company Notes issued by Private Company, with the principal balance of the Advance Notes plus all accrued interest being credited towards the Private Company Notes principal amount on a dollar-for-dollar basis. Under the terms of the Merger Agreement, the Company may solicit alternative acquisition proposals from third parties during a 30-day “go-shop” period beginning on the date of the Merger Agreement. There can be no assurances that the “go-shop” will result in a superior proposal. The Company does not intend to disclose developments related to the solicitation process until it determines whether such disclosure is appropriate or is otherwise required. The Bidder states in the Proposal that, while the Proposed Transaction would not be subject to a financing condition to pay the purchase price in the Proposed Transaction, the Bidder’s expectation is that, concurrent with the consummation of the Proposed Transaction, Buyer or its affiliates would complete a financing for purposes of raising funds to operate the Issuer after the Proposed Transaction. In addition, the Bidder states in the Proposal that the Proposal is conditioned on certain other to be identified Issuer stockholders agreeing to roll their existing equity into Buyer in the Proposed Transaction. The terms of any potential agreement between GreenLight and Fall Line would be contingent on certain conditions, including completion of due diligence review and negotiation of definitive transaction documents, as well as certain to be identified Company stockholders agreeing to roll their existing equity in connection with the Proposed Transaction. No assurance can be given that a definitive transaction with respect to Fall Line’s indication of interest or any other potential transaction will eventually be consummated. The transaction was negotiated on behalf of the Company by a Special Committee of its Board of Directors (the “Special Committee”) composed entirely of independent directors with the assistance of independent financial and legal advisors. Following the Special Committee’s unanimous recommendation, the Company’s Board of Directors unanimously approved the Merger Agreement and has recommended that the Company’s stockholders tender their shares of Company Common Stock in the Offer. Subject to customary closing conditions, the Company expects the transaction to close in the third quarter of 2023. As of July 19, 2023, a total of 18,791,264 Shares were validly tendered and not validly withdrawn pursuant to the Offer as of the Expiration Date, representing approximately 60.36% of the outstanding Shares other than Rollover Shares. As of the expiration of the Offer, the number of Shares validly tendered and not validly withdrawn pursuant to the Offer satisfied the Minimum Condition. As of June 21, 2023, the offer is scheduled to expire on July 19, 2023. Goodwin Procter LLP acted as legal advisor to GreenLight Biosciences Holdings in the transaction. Roth Capital Partners, LLC is serving as financial advisor and Foley Hoag LLP is serving as legal counsel to the Special Committee. O’Melveny & Myers LLP is serving as legal counsel to Fall Line. ROTH Capital Partners, LLC acted as fairness opinion provider to the special committee. Continental Stock Transfer & Trust Company acted as depositary to GreenLight. A group of buyers led by Fall Line Endurance Fund, Lp, managed by Fall Line Capital, LLC completed the acquisition of GreenLight Biosciences Holdings (NasdaqGM:GRNA) from stockholders on July 24, 2023.

Capital Markets 収益成長	7.5%
収益成長率	12.5%
将来の株主資本利益率	14.64%
アナリストカバレッジ	Good
最終更新日	06 Aug 2026

日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
12/31/2028	385	188	N/A	N/A	2
12/31/2027	419	209	N/A	N/A	9
12/31/2026	370	175	N/A	N/A	7
6/30/2026	313	141	-594	-593	N/A
3/31/2026	300	138	-519	-518	N/A
12/31/2025	280	136	-536	-535	N/A
9/30/2025	268	142	-353	-352	N/A
6/30/2025	255	139	-401	-400	N/A
3/31/2025	240	128	-299	-299	N/A
12/31/2024	227	116	-317	-317	N/A
9/30/2024	205	87	-472	-472	N/A
6/30/2024	191	80	-186	-184	N/A
3/31/2024	184	69	-201	-198	N/A
12/31/2023	175	77	-99	-96	N/A
9/30/2023	171	58	-13	-11	N/A
6/30/2023	163	29	-57	-55	N/A
3/31/2023	151	1	-163	-163	N/A
12/31/2022	139	-30	-236	-236	N/A
9/30/2022	120	26	-323	-322	N/A
6/30/2022	103	66	-383	-382	N/A
3/31/2022	89	98	-275	-274	N/A
12/31/2021	77	132	-243	-242	N/A
9/30/2021	70	87	-160	-159	N/A
6/30/2021	61	72	-102	-101	N/A
3/31/2021	57	54	-80	-79	N/A
12/31/2020	51	-6	-58	-58	N/A

データ	最終更新日（UTC時間）
企業分析	2026/08/06 03:34
終値	2026/08/05 00:00
収益	2026/06/30
年間収益	2025/12/31

パッケージ	データ	タイムフレーム	米国ソース例
会社財務	10年	損益計算書キャッシュ・フロー計算書貸借対照表	SECフォーム10-K SECフォーム10-Q
アナリストのコンセンサス予想	+プラス3年	予想財務アナリストの目標株価	アナリストリサーチレポート Blue Matrix
市場価格	30年	株価配当、分割、措置	ICEマーケットデータ SECフォームS-1
所有権	10年	トップ株主インサイダー取引	SECフォーム4 SECフォーム13D
マネジメント	10年	リーダーシップ・チーム取締役会	SECフォーム10-K SECフォームDEF 14A
主な進展	10年	会社からのお知らせ	SECフォーム8-K

アナリスト	機関
Mitchel Penn	Brean Capital Historical (Janney Montgomery)
Sean-Paul Adams	B. Riley Securities, Inc.
Brian Mckenna	Citizens JMP Securities, LLC

Trinity Capital 将来の成長

Future 基準チェック /36

主要情報

今後の成長に関する最新情報

Trinity Capital Inc. Announces Preliminary Earnings Guidance for the Fourth Quarter Ended December 31, 2025

Recent updates

New major risk - Shareholder dilution

Upcoming dividend of US$0.17 per share

Trinity Capital Inc. Declares Monthly Cash Dividend for July, August, and September 2026, Payable on July 31, 2026, August 31, 2026 and September 30, 2026 Respectively

Upcoming dividend of US$0.17 per share

Trinity Capital Inc. (NasdaqGS:TRIN) acquired Equipment Leasing Services Inc.

Insufficient new directors

Trinity Capital Inc. has filed a Follow-on Equity Offering in the amount of $300 million.

Trinity Capital Inc., Annual General Meeting, Jun 10, 2026

Trinity Capital Inc. Declares Monthly Regular Dividend for April, May, and June 2026, Payable on April 30, 2026, May 29, 2026 and June 30, 2026, Respectively

Fullmind acquired EdBlox, Inc.

Trinity Capital Inc. Announces Preliminary Earnings Guidance for the Fourth Quarter Ended December 31, 2025

Trinity Capital Inc. to Report Q3, 2026 Results on Nov 04, 2026

Trinity Capital Inc. Declares Dividend for the Fourth Quarter Ending December 31, 2025, Payable on January 15, 2026; Declares Monthly Regular Dividends for Each of January, February, and March 2026, Payable on January 30, 2026, February 27, 2026 and March 31, 2026 Respectively

LendingClub Corporation (NYSE:LC) agreed to acquire Wisetack, Inc.

Trinity Capital Inc. Provides Equipment Financing to Bobbie, Bolstering Domestic Infant Formula Industry

Trinity Capital Inc. Appoints Paul D'agrosa as Managing Director of Life Sciences

Trinity Capital Inc. Declares Cash Dividend for the Third Quarter of 2025, Payable on October 15, 2025

Trinity Capital Inc. Announces Appointment of Brian Geraghty as Managing Director of Equipment Finance

Trinity Capital Inc. has filed a Follow-on Equity Offering in the amount of $250 million.

Trinity Capital Inc. Appoints Josh Mackey as Director of Tech Lending

V2 Food Pty Ltd acquired Daring Foods Inc.

Eosx SPACESHIP Company SL acquired Space Perspective Inc.

CoreWeave, Inc. (NasdaqGS:CRWV) signed a definitive agreement to acquire Core Scientific, Inc. (NasdaqGS:CORZ) for $6.8 billion.

Trinity Capital Inc. Declares Cash Dividend for the Second Quarter Ending June 30 2025, Payable on July 15, 2025

Trinity Capital Inc., Annual General Meeting, Jun 12, 2025

Trinity Capital Inc. announces Quarterly dividend, payable on April 15, 2025

Trinity Capital Inc. Appoints Zach Taffet as Director of Capital Formation & Investor Relations

Trinity Capital Inc Appoints John Orlando as Managing Director of Life Sciences

Grovecourt Capital Partners acquired IMRIS Inc. (OTCPK:IMRS.Q).

Trinity Capital Inc. to Report Q2, 2025 Results on Aug 06, 2025

Koito Manufacturing Co., Ltd. (TSE:7276), Jun Pei, Jun Ye and Marc Accord completed the acquisition of Cepton, Inc. (NasdaqCM:CPTN) from Koito Manufacturing Co., Ltd. (TSE:7276), Jun Pei, Jun Ye and Marc Accord and others.

Insufficient new directors

Third quarter dividend of US$0.51 announced

Founder & Executive Chairman recently bought €233k worth of stock

Trinity Capital Inc. announced that it has received $142.5 million in funding

Second quarter dividend of US$0.51 announced

Koito Manufacturing Co., Ltd. (TSE:7276) entered into a definitive agreement to acquire Cepton, Inc. (NasdaqCM:CPTN) from Koito Manufacturing Co., Ltd. (TSE:7276) and others for $55.3 million.

Trinity Capital Inc. Announces Appointment of Joshua Ruben as Managing Director of Life Sciences

First quarter dividend of US$0.51 announced

Trinity Capital Inc. Appoints Craig Fox as Managing Director

Trinity Capital Inc. Announces Director Appointments

New major risk - Earnings quality

Trinity Capital Inc., Annual General Meeting, Jun 12, 2024

Upcoming dividend of US$0.51 per share

Fourth quarter dividend of US$0.51 announced

Trinity Capital Inc. to Report Q1, 2024 Results on May 01, 2024

Trinity Capital Inc. Appoints Brendan Carr as Director of Tech Lending

Trinity Capital Inc. Announces Chief Financial Officer Changes

Trinity Capital Inc. Appoints Ryan Kaeding as Managing Director, Life Sciences in San Diego, California

Showroom Interiors LLC acquired Feather Home Inc. and Fernished, Inc.

Trinity Capital Inc. Declares Cash Dividend for the Quarter Ending September 30, 2023, Payable on October 13, 2023

Trinity Capital Inc. Announces Regular Cash Dividend, Payable on October 13, 2023

Upcoming dividend of US$0.54 per share at 13% yield

Trinity Capital Inc. Announces Management Changes

Trinity Capital Inc. has completed a Follow-on Equity Offering in the amount of $75 million.

New minor risk - Shareholder dilution

A group of buyers led by Fall Line Endurance Fund, Lp, managed by Fall Line Capital, LLC completed the acquisition of GreenLight Biosciences Holdings (NasdaqGM:GRNA) from stockholders.

Trinity Capital Inc. Appoints Andrew Ghannam as Managing Director of Tech Lending

Upcoming dividend of US$0.53 per share at 14% yield

Trinity Capital Inc. Declares Cash Dividend for the Quarter Ending June 30, 2023, Payable on July 14, 2023

Upcoming dividend of US$0.47 per share at 14% yield

Trinity Capital Inc. to Report Q3, 2023 Results on Nov 02, 2023

Hut 8 Mining Corp. (TSX:HUT) entered into a definitive business combination agreement to acquire US Bitcoin Corp in a merger of equals

Molekule Group, Inc. (NasdaqCM:MKUL) acquired Molekule, Inc.

Trinity Capital Inc. Declares Cash Dividend for the Quarter Ending December 31, 2022, Payable on January 13, 2023

President recently bought €226k worth of stock

Intelligent Foods acquired Gobble Inc.

Trinity Capital Inc. (NasdaqGS:TRIN) announces an Equity Buyback for $25 million worth of its shares.

High number of new directors

Trinity Capital Inc. Appointment of Lauren Cosentino as Managing Director, Life Sciences in the Research Triangle Park Region of North Carolina

Trinity Capital Inc. Declares Cash Dividend for the Third Quarter of 2022, Payable on October 14, 2022

Trinity Capital Inc. has completed a Follow-on Equity Offering in the amount of $55 million.

Chairman & CEO recently bought €382k worth of stock

Trinity Capital Inc. to Report Q2, 2022 Results on Aug 04, 2022